PT97277A - Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante - Google Patents

Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante

Info

Publication number
PT97277A
PT97277A PT97277A PT9727791A PT97277A PT 97277 A PT97277 A PT 97277A PT 97277 A PT97277 A PT 97277A PT 9727791 A PT9727791 A PT 9727791A PT 97277 A PT97277 A PT 97277A
Authority
PT
Portugal
Prior art keywords
cyclosporin
xenoenxerto
aloenxerto
concording
collateral
Prior art date
Application number
PT97277A
Other languages
English (en)
Other versions
PT97277B (pt
Inventor
David James Graham White
Johan Beyers Van Den Bogaerde
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutran Ltd filed Critical Imutran Ltd
Publication of PT97277A publication Critical patent/PT97277A/pt
Publication of PT97277B publication Critical patent/PT97277B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
PT97277A 1990-04-09 1991-04-08 Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante PT97277B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007971A GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
PT97277A true PT97277A (pt) 1992-01-31
PT97277B PT97277B (pt) 1998-08-31

Family

ID=10674123

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97277A PT97277B (pt) 1990-04-09 1991-04-08 Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante

Country Status (22)

Country Link
EP (1) EP0527762B1 (pt)
JP (1) JP3518547B2 (pt)
CN (1) CN1040178C (pt)
AT (1) ATE141167T1 (pt)
AU (1) AU7555591A (pt)
CZ (1) CZ283119B6 (pt)
DE (1) DE69121401T2 (pt)
DK (1) DK0527762T3 (pt)
ES (1) ES2090325T3 (pt)
GB (1) GB9007971D0 (pt)
GR (1) GR3021642T3 (pt)
HK (1) HK48597A (pt)
IE (1) IE911153A1 (pt)
IL (1) IL97788A (pt)
IN (1) IN173149B (pt)
MY (1) MY106158A (pt)
NZ (1) NZ237739A (pt)
PT (1) PT97277B (pt)
SG (1) SG47465A1 (pt)
SK (1) SK279949B6 (pt)
WO (1) WO1991015221A1 (pt)
ZA (1) ZA912467B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60020727T2 (de) * 1999-10-27 2006-05-04 Robert London Zhong Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
EP1365798B1 (en) 2000-09-29 2009-12-30 Viron Therapeutics, Inc. Use of serp-1 in combination with an immunosuppressant for treating arthritis
PT1755674E (pt) * 2004-05-14 2015-02-05 Alexion Pharma Inc Prolongamento da sobrevivência de um aloenxerto por inibição da atividade do complemento
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
PL3028716T3 (pl) 2006-10-10 2021-03-08 Regenesance B.V. Hamowanie układu dopełniacza służące do lepszej regeneracji nerwów
EP3121197A1 (en) * 2008-11-10 2017-01-25 Alexion Pharmaceuticals, Inc. Methods and compositions for treating complement-associated disorders
EP4300103A3 (en) 2013-08-07 2024-02-28 Alexion Pharmaceuticals, Inc. Atypical hemolytic uremic syndrome (ahus) biomarker proteins

Also Published As

Publication number Publication date
AU7555591A (en) 1991-10-30
DE69121401T2 (de) 1996-12-12
CN1040178C (zh) 1998-10-14
EP0527762A1 (en) 1993-02-24
HK48597A (en) 1997-04-25
ZA912467B (en) 1992-12-30
IE911153A1 (en) 1991-10-09
WO1991015221A1 (en) 1991-10-17
JPH05507266A (ja) 1993-10-21
JP3518547B2 (ja) 2004-04-12
SK279949B6 (sk) 1999-06-11
EP0527762B1 (en) 1996-08-14
IL97788A0 (en) 1992-06-21
NZ237739A (en) 1993-09-27
GR3021642T3 (en) 1997-02-28
ES2090325T3 (es) 1996-10-16
DE69121401D1 (de) 1996-09-19
CN1056240A (zh) 1991-11-20
IN173149B (pt) 1994-02-19
CZ283119B6 (cs) 1998-01-14
SG47465A1 (en) 1998-04-17
GB9007971D0 (en) 1990-06-06
CS9100988A2 (en) 1991-12-17
DK0527762T3 (da) 1996-09-02
ATE141167T1 (de) 1996-08-15
MY106158A (en) 1995-03-31
PT97277B (pt) 1998-08-31
IL97788A (en) 1998-02-08

Similar Documents

Publication Publication Date Title
IT8720689A0 (it) Procedimento e impianto per la separazione di sostanze leggere da miscele di substrati.
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
MX173183B (es) Uso de la rapamicina para la preparacion de una composicion para inhibir el rechazo de transplantes de organos o tejidos en un mamifero que lo necesita
CO4700485A1 (es) Anticuerpos anti-icam-1 modificados y su uso en el tratamiento de inflamaciones
ES2016585B3 (es) Polibutilaminas y poliisobutilaminas, procedimiento para su preparacion y composiciones combustibles y lubricantes que contienen estas sustancias.
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
ES2063013T3 (es) Procedimiento para eliminar pirogenos.
ES2179052T3 (es) Composicion farmaceutica que contiene un derivado de ciclosporina.
MX9302461A (es) Benzo-y piridopiridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
PT97277A (pt) Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante
ES2065698T3 (es) Autobioticos y su utilizacion para eliminar in vivo celulas extrañas.
DK0408711T3 (da) S-adenosylmethionin til behandling af pancreatitis og immunafstødning ved pancreastransplantationer
DE3750493D1 (de) Flüssige sterilisierende Zusammensetzung.
ES2013727B3 (es) Procedimiento para la fabricacion de articulos de cerdas y articulos de cerdas fabricadas por dicho procedimiento.
ES2187534T3 (es) Procedimiento para la preparacion de n-metil-3-(metil-4-piperi dinil)-14-indol-5-etanosulfonamida.
ES2048142T3 (es) Procedimiento de obtencion de polidesoxirribonucleotidos sustancialmente puros y no informacionales que tienen actividades biologicas, y producto respectivo.
AR240485A1 (es) Composicones activadroas, exentas de titanio,procedimietno para obtenerlas yprocedimiento para activar superfices metalicas antes de su fosfatacion al zionc que emplea dichos fosfatos.
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
DK532087D0 (da) Farmaceutiske praeparater til behandling af hjernelidelser paa funktional og organisk basis
ES2108418T3 (es) Oligosacaridos con actividad biologica y preparacion de los mismos a partir de glicosaminoglicanos.
IT1237514B (it) Composti ad attivita' antitussiva, processo per la loro preparazione, loro composizioni farmaceutiche.
Tyroler Nicaraguan President: Abrams' References To Mexico & Peru" warmongering & Disrespectful"
ES2063057T3 (es) Esteres aromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
SE8302976D0 (sv) Pharmaceutical compositions containing at least one polyfluorinated alcohol

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910911

FG3A Patent granted, date of granting

Effective date: 19980504

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20071105